The Koffee With Karan maker is selling 50% to its shares to Serene Productions, which is led by pharmaceutical tycoon Adar Poonawalla, for 1,000 crore ($120M). The binding agreement values Dharma ...

Pharmaceutical tycoon Adar Poonawalla’s Serene Productions is investing $119 million in Indian media personality Karan Johar ‘s Dharma Productions and Dharmatic Entertainment.

Pharmaceutical tycoon Adar Poonawalla’s Serene Productions is investing $119 million in Indian media personality Karan Johar’s Dharma Productions and Dharmatic Entertainment. The deal values ...

Serene Productions—led by businessman Adar Poonawalla, son of Indian vaccine billionaire Cyrus Poornawalla—plans to invest $118 million for a 50% stake in Bollywood film maker Dharma Productions.

Serum Institute of India CEO Adar Poonawalla took a jibe at the ongoing 90-hour workweek. In a post on X, he tagged industrialist Anand Mahindra and said "My wife loves staring at me on Sundays." ...

Adar Poonawalla, CEO of vaccine maker Serum Institute of India, will buy a 50% stake in filmmaker Karan Johar's Dharma Productions for 10 billion rupees ($119 million), the Bollywood studio said ...

Billionaire businessman Adar Poonawalla’s Serene Productions will invest 10 billion rupees ($119 million) in Indian producer Karan Johar’s Dharma Productions and Dharmatic Entertainment, the ...

MUMBAI, (REUTERS) – Adar Poonawalla, CEO of vaccine maker Serum Institute of India, will buy a 50% stake in filmmaker Karan Johar’s Dharma Productions for 10 billion rupees ($119 million), the ...

Adar Poonawalla, CEO of the Serum Institute of India, offered critical insights into leveraging technology and innovation to ensure global vaccine access. “We operate with a semi-philanthropic ...

Meanwhile, sources say that Adar's rumoured initial offer to sponsor the construction of the clubhouse on behalf of his father Cyrus Poonawalla, is likely to get shared by his uncle Zavaray ...

SII CEO Adar Poonawalla said on Saturday that its partnership for a Covid-19 vaccine with Novavax has shown excellent efficacy results. "We have applied for starting trials in India.